These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38326550)

  • 1. Collusion risk in corporate networks.
    Villamil I; Kertész J; Fazekas M
    Sci Rep; 2024 Feb; 14(1):3161. PubMed ID: 38326550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A network approach to cartel detection in public auction markets.
    Wachs J; Kertész J
    Sci Rep; 2019 Jul; 9(1):10818. PubMed ID: 31346221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling market power and price spikes in electricity networks: Demand-side bidding.
    Rassenti SJ; Smith VL; Wilson BJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2998-3003. PubMed ID: 16576750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex network motifs as building blocks of corporate networks.
    Takes FW; Kosters WA; Witte B; Heemskerk EM
    Appl Netw Sci; 2018; 3(1):39. PubMed ID: 30839798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management or technology? Firms' embeddedness in dual talent flow networks and their innovation performance.
    Sun B; Ruan A; Peng B; Liu S
    Front Psychol; 2022; 13():1028818. PubMed ID: 36425841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation of the Tendency of Vertical Collusion in Construction Bidding Based on Deep Neural Network.
    Zhu W; Cheng K; Guo Y; Chen Y
    Comput Intell Neurosci; 2022; 2022():2897672. PubMed ID: 35875775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between perceived institutional conditions and firm-level innovations in emerging markets: Moderating effects of firm ownerships.
    Odei SA
    PLoS One; 2024; 19(1):e0291290. PubMed ID: 38252618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of competitive bidding by providers for indigent medical care contracts.
    Kirkman-Liff BL; Christianson JB; Hillman DG
    Health Serv Res; 1985 Dec; 20(5):549-77. PubMed ID: 4086301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Institutional pressures as drivers of corporate green innovation: do provincial officials and CEOs matter?
    Ren S; Wang M
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40608-40629. PubMed ID: 36622586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the influence of global innovation networks on corporate innovation: evidence from the international semiconductor industry.
    Wu Y; Ding L; Li N; Yu X
    Sci Rep; 2024 May; 14(1):11007. PubMed ID: 38745006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of energy consumption structure transformation on firms' total factor productivity: evidence from China.
    Zhang Z; Ma Y
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76950-76968. PubMed ID: 37249767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supply network position, digital transformation and innovation performance: Evidence from listed Chinese manufacturing firms.
    Du C; Zhang Q
    PLoS One; 2022; 17(12):e0279133. PubMed ID: 36520812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Price offers of pharmaceutical procurement in China: evidence from Guangdong province.
    Yao Y; Tanaka M
    Eur J Health Econ; 2016 Jun; 17(5):563-75. PubMed ID: 26072419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition in the economic crisis: Analysis of procurement auctions.
    Gugler K; Weichselbaumer M; Zulehner C
    Eur Econ Rev; 2015 Jan; 73():35-57. PubMed ID: 25673884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking What I Say and What I Do: Evidence From Perceived Competition Networks.
    Chen F; Xu J; Wang W; Liao F; Guo Y
    Front Psychol; 2022; 13():887510. PubMed ID: 35645854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock.
    Wang XX; Jiao HY
    Front Public Health; 2022; 10():980845. PubMed ID: 36033805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interdependence of corporate reputation and ownership: a network approach to quantify reputation.
    Zhang Y; Schweitzer F
    R Soc Open Sci; 2019 Oct; 6(10):190570. PubMed ID: 31824691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving beyond Stylized Economic Network Models: The Hybrid World of the Indian Firm Ownership Network.
    Mani D; Moody J
    AJS; 2014 Jun; 119(8):1629-1669. PubMed ID: 25418990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to effectively control vertical collusion in bidding for government investment projects-Based on fsQCA method.
    Ma C; Chen Y; Zhu W; Ou L
    PLoS One; 2022; 17(9):e0274002. PubMed ID: 36099271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corporate climate risk and stock market reaction to performance briefings in China.
    Wu N; Xiao W; Liu W; Zhang Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53801-53820. PubMed ID: 35290587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.